Your browser doesn't support javascript.
loading
Hydroxychloroquine and COVID-19: can we learn from the use of rituximab in systemic lupus erythematosus?
Lekpa, Fernando Kemta; Ngahane, Bertrand Hugo Mbatchou; Njonnou, Sylvain Raoul Simeni; Fouda, Hermine; Halle, Marie Patrice; Njankouo, Yacouba Mapoure; Dzudie, Anastase; Choukem, Simeon Pierre; Luma, Henry Namme.
Afiliação
  • Lekpa FK; Internal Medicine Department, Douala General Hospital, Douala, Cameroon.
  • Ngahane BHM; Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
  • Njonnou SRS; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon.
  • Fouda H; Internal Medicine Department, Douala General Hospital, Douala, Cameroon.
  • Halle MP; Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
  • Njankouo YM; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon.
  • Dzudie A; Internal Medicine Department, Douala General Hospital, Douala, Cameroon.
  • Choukem SP; Internal Medicine Department, Douala General Hospital, Douala, Cameroon.
  • Luma HN; Internal Medicine Department, Douala General Hospital, Douala, Cameroon.
Pan Afr Med J ; 38: 372, 2021.
Article em En | MEDLINE | ID: mdl-34367451
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rituximab / Tratamento Farmacológico da COVID-19 / Hidroxicloroquina / Fatores Imunológicos / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rituximab / Tratamento Farmacológico da COVID-19 / Hidroxicloroquina / Fatores Imunológicos / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article